Article by Uttara Choudhury, Proactive Investors
On January 9, the two companies confirmed a sales agreement. Under the pact, Shoppers Drug Mart will be the exclusive direct-to-patient online provider of FlowrRx products. Previously, FlowrRx products were available online to patients registered via Flowr’s website.
The company said the relationship with Shoppers Drug Mart represents a “milestone in the de-stigmatization of medical cannabis.”
Shoppers Drug Mart bills itself as the first Canadian retail pharmacy chain to offer a variety of cannabis products to medical cannabis patients, but while product information is available nationally, it can initially only sell medical cannabis to patients in Ontario, through its shoppersdrugmart.ca/cannabis site.
“We’re pleased to provide patients with the high quality and consistent products they seek, now with access to the world class patient care team that Shoppers Drug Mart has assembled,” said Flowr Corp co-CEO Vinay Tolia. “Flowr’s premium medical cannabis is grown in what we believe is the industry’s most advanced Good Manufacturing Practice (GMP)-designed cultivation facility. This relationship is testament to our commitment to ultra-high-quality cannabis cultivation and further solidifies Flowr’s role in Canada’s medical cannabis landscape.”